StonvexLoading…
StonvexStonvexStonvexCore line items from EXK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $467.50M | $217.60M | $205.46M | $210.16M |
Operating Income | $35.70M | $8.30M | $8.70M | $23.46M |
Net Income | $-119.10M | $-31.50M | $6.12M | $6.20M |
EPS (Diluted) | $-0.42 | $-0.13 | $0.03 | $0.03 |
Total Assets | $1.24B | $719.20M | $474.81M | $399.44M |
Total Liabilities | $656.60M | $234.80M | $88.47M | $83.54M |
Cash & Equivalents | $215.40M | $106.40M | $35.29M | $83.39M |
Free Cash Flow OCF − CapEx | $-101.80M | $-176.30M | $-106.02M | $-54.72M |
Shares Outstanding | Not available | Not available | 217.25M | 190.00M |